Boselli F, De Martis S, Rivasi F, Toni A, Abbiati R, Chiossi G
Department of Gynaecological, Obstetric, and Paediatric Sciences, Section of Obstetrics and Gynaecology, University of Modena and Reggio Emilia, Az Policlinico, Italy.
J Med Screen. 2000;7(3):160-2. doi: 10.1136/jms.7.3.160.
The main objective of the study was to evaluate if speculoscopy, a magnified chemiluminescent examination, combined with a Pap smear, could improve the detection of early cervical lesions compared with the Pap smear alone.
Pap tests and speculoscopies were performed in two family planning centres located in the surrounding areas of Modena. Colposcopic investigations and biopsies of the uterine cervix were performed in a second level centre (Gynaecological Prevention Centre of Modena Policlinico). Histological specimens were analysed at the Section of Pathological Anatomy of Modena Policlinico.
The study population comprised 1000 women aged 25-64 years, invited to undergo a Pap smear every three years in accordance with the screening programme for cervical cancer started in Modena in 1997.
Midwives performed the Pap smear and speculoscopy in succession. Women with a positive Pap test and/or positive speculoscopy underwent colposcopy and, if colposcopic findings were positive, targeted punch biopsies were performed.
A total of 1000 patients were subjected to cytology and speculoscopy examinations. Among these women, 10 had abnormal Pap smear findings whereas 144 had an abnormal speculoscopic pattern. Only three of 59 patients with a histological diagnosis of cervical intraepithelial neoplasia grade I (CIN I)/human papillomavirus and only three of seven patients with CIN II/CIN III had a positive Pap test.
Speculoscopy combined with a Pap test can significantly increase the detection of cervical lesions when included in a screening programme.
本研究的主要目的是评估,与单独的巴氏涂片检查相比,阴道镜检查(一种放大的化学发光检查)联合巴氏涂片是否能提高早期宫颈病变的检测率。
巴氏试验和阴道镜检查在位于摩德纳周边地区的两个计划生育中心进行。宫颈的阴道镜检查和活检在二级中心(摩德纳综合医院妇科预防中心)进行。组织学标本在摩德纳综合医院病理解剖科进行分析。
研究人群包括1000名年龄在25 - 64岁之间的女性,她们按照1997年在摩德纳启动的宫颈癌筛查计划,每三年接受一次巴氏涂片检查。
助产士依次进行巴氏涂片和阴道镜检查。巴氏试验阳性和/或阴道镜检查阳性的女性接受阴道镜检查,如果阴道镜检查结果为阳性,则进行靶向穿刺活检。
共有1000名患者接受了细胞学和阴道镜检查。在这些女性中,10人巴氏涂片检查结果异常,而144人阴道镜检查结果异常。在59例组织学诊断为宫颈上皮内瘤变1级(CIN I)/人乳头瘤病毒的患者中,只有3例巴氏试验阳性;在7例CIN II/CIN III患者中,也只有3例巴氏试验阳性。
在筛查计划中,阴道镜检查联合巴氏试验可显著提高宫颈病变的检测率。